Sequence of echocardiographic changes during development of right ventricular failure in rat.

[1]  Ladislav Dusek,et al.  Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  W. Casscells,et al.  Hypothermia is a bedside predictor of imminent death in patients with congestive heart failure. , 2005, American heart journal.

[3]  E. Bossone,et al.  Pulmonary arterial hypertension: the key role of echocardiography. , 2005, Chest.

[4]  F. Haaijer-Ruskamp,et al.  Management of heart failure in The Netherlands , 2005, European journal of heart failure.

[5]  S. Goodlin.  Heart failure in the elderly , 2005, Expert review of cardiovascular therapy.

[6]  J. Dyck,et al.  Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis , 2004, Circulation research.

[7]  P. Singal,et al.  Antioxidant and oxidative stress changes in experimental cor pulmonale , 2004, Molecular and Cellular Biochemistry.

[8]  T. Yokoi,et al.  Progressive development of pulmonary hypertension leading to right ventricular hypertrophy assessed by echocardiography in rats. , 2003, Experimental animals.

[9]  H. White,et al.  Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. , 2003, Journal of the American College of Cardiology.

[10]  D. Chemla,et al.  Haemodynamic evaluation of pulmonary hypertension , 2002, European Respiratory Journal.

[11]  J. Loscalzo,et al.  Serial noninvasive assessment of progressive pulmonary hypertension in a rat model. , 2002, American journal of physiology. Heart and circulatory physiology.

[12]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[13]  F. Brunner,et al.  Calcium handling and role of endothelin-1 in monocrotaline right ventricular hypertrophy of the rat. , 2000, Journal of molecular and cellular cardiology.

[14]  D. Yeshurun,et al.  Heart diseases affecting the liver and liver diseases affecting the heart. , 2000, American heart journal.

[15]  L. Tavazzi,et al.  Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. , 2000, The American journal of cardiology.

[16]  O. Burghuber,et al.  Accuracy of echocardiographic right ventricular parameters in patients with different end-stage lung diseases prior to lung transplantation. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  F. Brunner,et al.  Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat. , 1999, Cardiovascular research.

[18]  S. Doggrell,et al.  Rat models of hypertension, cardiac hypertrophy and failure. , 1998, Cardiovascular research.

[19]  J B Seward,et al.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.

[20]  J. Sprung,et al.  Effects of Ketamine on the Contractility of Failing and Nonfailing Human Heart Muscles In Vitro , 1998, Anesthesiology.

[21]  C. Leier,et al.  The pharmacokinetics of midazolam in patients with congestive heart failure. , 1990, British journal of clinical pharmacology.

[22]  R. Ferrari,et al.  Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. , 1989, Cardiovascular research.

[23]  N. Reichek,et al.  Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. , 1989, Circulation.

[24]  A. Gerdes,et al.  Right ventricular performance after monocrotaline-induced pulmonary hypertension. , 1989, The American journal of physiology.

[25]  F. Nistal,et al.  Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. , 1986, The American journal of cardiology.

[26]  M. Isobe,et al.  Prediction of pulmonary arterial pressure in adults by pulsed Doppler echocardiography. , 1986, The American journal of cardiology.

[27]  L. Pieri.  Preclinical pharmacology of midazolam. , 1983, British journal of clinical pharmacology.

[28]  F. Ghodsi,et al.  Changes in pulmonary structure and function induced by monocrotaline intoxication. , 1981, The American journal of physiology.

[29]  L. Reid,et al.  Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. , 1980, The American journal of physiology.

[30]  O. Trojnarska.  Heart failure in the adult patient with congenital heart disease. , 2007, Cardiology journal.

[31]  K. Tanonaka,et al.  Preferable anesthetic conditions for echocardiographic determination of murine cardiac function. , 2005, Journal of pharmacological sciences.

[32]  R. Ferrari,et al.  Effect of nolomirole on monocrotaline-induced heart failure. , 2004, Pharmacological research.

[33]  M. Jessup,et al.  Heart failure. , 2003, The New England journal of medicine.

[34]  S. Yusuf,et al.  Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. , 2001, Journal of the American College of Cardiology.